Maria Osama Muhammad, Eliopoulos Nicoletta, Muanza Thierry
Faculty of Medicine, Experimental Medicine Department, McGill University, Montreal, QC, Canada.
Radiation Oncology Department, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Front Oncol. 2017 May 22;7:89. doi: 10.3389/fonc.2017.00089. eCollection 2017.
Radiation-induced oral mucositis (RIOM) is a major dose-limiting toxicity in head and neck cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has marked adverse effects on patient quality of life and cancer therapy continuity. It is a challenge for radiation oncologists since it leads to cancer therapy interruption, poor local tumor control, and changes in dose fractionation. RIOM occurs in 100% of altered fractionation radiotherapy head and neck cancer patients. In the United Sates, its economic cost was estimated to reach 17,000.00 USD per patient with head and neck cancers. This review will discuss RIOM definition, epidemiology, impact and side effects, pathogenesis, scoring scales, diagnosis, differential diagnosis, prevention, and treatment.
放射性口腔黏膜炎(RIOM)是头颈癌患者主要的剂量限制性毒性反应。它是由放射治疗(RT)引起的正常组织损伤,对患者生活质量和癌症治疗的连续性有显著不良影响。这对放射肿瘤学家来说是一项挑战,因为它会导致癌症治疗中断、局部肿瘤控制不佳以及剂量分割的改变。100%接受分割放疗的头颈癌患者会发生RIOM。在美国,据估计每位头颈癌患者的经济成本高达17,000.00美元。本综述将讨论RIOM的定义、流行病学、影响和副作用、发病机制、评分量表、诊断、鉴别诊断、预防及治疗。